We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




First AI-Powered Ultrasound Technique Destroys Wide Range of Deadly Cancerous Tumors

By HospiMedica International staff writers
Posted on 07 Dec 2023

Focused ultrasound treatment, which employs high-frequency sound waves to generate a strong beam that heats and destroys cancer cells, has been a treatment option since the 1970s. More...

It's been applied to various cancers, including those of the prostate, breast, liver, and others, offering a non-surgical approach that eliminates the need for incisions. While this method allows for outpatient surgery and a swifter, less painful recovery for patients, it faces significant challenges that hinder its broader adoption. One major issue is the lack of precise control during the procedure, leading to potential harm to healthy tissue adjacent to a tumor or incomplete treatment of the tumor itself, potentially allowing cancer to spread. To overcome these limitations, engineers are now integrating artificial intelligence (AI) to enhance the visualization and control of this non-invasive cancer treatment, aiming to increase its efficacy and safety in eliminating a wide array of cancerous tumors.

Engineers from the University of Waterloo (Ontario, Canada) have developed an advanced system that utilizes hardware derived from a focused ultrasound transducer. This device is essential in delivering ultrasound energy precisely to the targeted area. Alongside, they utilized an ultrasound imaging probe to acquire images at the treatment site. The precision of alignment between the ultrasound probe and transducer is crucial for accurate monitoring, as the treatment area is typically small, ranging from millimeters to centimeters. The engineers employed a robotic arm to maintain this alignment, ensuring accurate imaging throughout the treatment as the transducer moves.

The software aspect involves an AI framework integrated into the imaging process. During the treatment, the AI swiftly compares ultrasound images taken before and after each application. Remarkably, the framework processes 45 frames of ultrasound images per second, fast enough to synchronize with ultrasound imaging systems for real-time monitoring of the treatment. It can detect changes in the treatment area in less than 22 milliseconds. Due to this rapid processing, the system can ascertain the extent of tumor destruction with 93% accuracy, allowing doctors to pinpoint the ablated area's margin with micrometer-level precision. This advancement promises to enhance the control surgeons have over-focused ultrasound treatments, ensuring complete tumor eradication while safeguarding healthy tissue. Building on these encouraging research findings, the team plans to refine their method further for tracking the growth of a treated area in real time during the procedure.

“We are addressing a huge challenge for focused ultrasound treatment,” said project leader Moslem Sadeghi Goughari. “Our imaging system can tell doctors exactly how much of a cancerous tissue is destroyed. And it’s the first AI-powered ultrasound technique developed for focused ultrasound treatment.”

Related Links:
University of Waterloo


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.